Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
PharmAkea Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
PharmAkea Therapeutics

PharmAkea Therapeutics

Acquired

PharmAkea: Biopharmaceutical firm developing small molecule drugs for fibroproliferative diseases.

HQ
San Diego, CA, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

PharmAkea Therapeutics, founded with a mission to develop innovative treatments for fibroproliferative diseases, focuses on creating small molecule drug candidates. The company's vision is to address unmet medical needs by targeting specific proteins involved in these diseases. PharmAkea's primary market includes patients suffering from conditions characterized by excessive tissue growth and fibrosis, aiming to improve their quality of life through advanced biopharmaceutical solutions.

Notable figures affiliated with PharmAkea include experienced leaders in the biopharmaceutical industry, though specific names are not provided. The company has attracted significant attention and investment due to its promising drug development pipeline. Key achievements include the advancement of multiple drug candidates through various stages of clinical trials, underscoring its impact on the field of fibroproliferative disease treatment.

PharmAkea Therapeutics - Similar Companies

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Akebia Therapeutics logo

Akebia Therapeutics

akebia.com

Aureka Biotechnologies logo

Aureka Biotechnologies

aurekabio.com

Blade Therapeutics logo

Blade Therapeutics

D&D Pharmatech logo

D&D Pharmatech

Accera logo

Accera

Elgia Therapeutics logo

Elgia Therapeutics

Aristea Therapeutics logo

Aristea Therapeutics

SphynKx Therapeutics logo

SphynKx Therapeutics

Axikin Pharmaceuticals logo

Axikin Pharmaceuticals

Pharmatrophix logo

Pharmatrophix

pharmatrophix.com

Apie Therapeutics logo

Apie Therapeutics

Pliant Therapeutics logo

Pliant Therapeutics

pliantrx.com

Theracos logo

Theracos

theracos.com

Moerae Matrix logo

Moerae Matrix

moeraematrix.com

PharmAkea Therapeutics - Quick Facts

Who are PharmAkea Therapeutics' competitors?

Companies similar to PharmAkea Therapeutics include Aria Pharmaceuticals, Akebia Therapeutics, Aureka Biotechnologies and Blade Therapeutics.

When was PharmAkea Therapeutics founded?

PharmAkea Therapeutics was founded in 2012.

Where is PharmAkea Therapeutics' headquarters located?

PharmAkea Therapeutics' headquarters is located in San Diego, CA, US.

When was PharmAkea Therapeutics' last funding round?

PharmAkea Therapeutics' most recent funding round was for $10M (USD) in October 2013.

How much has PharmAkea Therapeutics raised to-date?

As of Oct 7, 2013, PharmAkea Therapeutics has raised a total of $10M (USD).

PharmAkea Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified